ADDISON, Texas, July 8, 2013 /PRNewswire/ -- ULURU Inc. (OTCQB:
ULUR) today announced the expansion of the Altrazeal®
international marketing network to include South Africa, Czech, Slovakia and Portugal.
Marketing and distribution agreements have been signed with
companies to exclusively distribute Altrazeal® in these
territories. Production of the initial product orders has commenced
and we are forecasting that these orders will be shipped in the
third quarter of 2013.
Commenting on the expansion of the Altrazeal®
international marketing network, Helmut
Kerschbaumer, Managing Director of Altrazeal Trading Ltd.,
stated "This expansion represents the first phase in appointing
marketing and distribution partners throughout the territory. Now
that we have a wealth of positive clinical data generated
internationally and the clear demonstration of the economic
benefits of Altrazeal® the interest by potential
partners has exceeded our expectations. With the increased exposure
of Altrazeal® at international wound care conferences,
we have received inquiries from countries throughout the territory
requesting the marketing rights for Altrazeal®. We
believe we are on schedule to have Altrazeal® marketed
in a total of 15-20 countries by year end."
About ULURU Inc.:
ULURU Inc. is a specialty pharmaceutical company focused
on the development of a portfolio of wound management and oral care
products to provide patients and consumers improved clinical
outcomes through controlled delivery utilizing its innovative
Nanoflex® Aggregate technology and OraDisc™ transmucosal
delivery system. For further information about ULURU Inc., please
visit our website at www.uluruinc.com. For further
information about Altrazeal®, please visit our website
at www.altrazeal.com.
This press release contains certain statements that are
forward-looking within the meaning of Section 27a of the Securities
Act of 1933, as amended, including but not limited to statements
made relating to the response of potential partners related to the
benefits of Altrazeal®, and the expectation of marketing
Altrazeal® in new territories. When used in this
press release, the words "believe," "expect" and "anticipate" and
similar expressions may be indicative of forward-looking
statements. These statements by their nature involve
substantial risks and uncertainties, certain of which are beyond
the Company's control. Any forward-looking statement speaks only as
of the date on which such statement is made, and the Company
undertakes no obligation to update any forward-looking. These
statements are subject to numerous risks and uncertainties,
including but not limited to the risk factors detailed in the
Company's Annual Report on Form 10-K for the year ended
December 31, 2012 and other reports
filed by us with the Securities and Exchange Commission.
Contact: Company
Kerry P. Gray
President & CEO
Terry K. Wallberg
Vice President & CFO
(214) 905-5145
SOURCE ULURU Inc.